A.P. Møller - Mærsk A/S
8.3.2021 13:40:17 CET | Globenewswire | Press release
| A.P. Møller - Mærsk A/S – Transactions in connection with share buy-back program | |||
| On 30 November 2020, A.P. Møller - Mærsk A/S (the Company) announced first phase of a share buy-back program in compliance with the EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). The share buy-back program of up to DKK 10bn is to be executed during a 15-month period beginning 1 December 2020. | |||
| During the first phase of the program running from 1 December 2020 up to 29 April 2021, the Company will buy-back A and B shares for an amount of up to DKK 3.3bn. | |||
| The following transactions have been made under the program in the period 1 March 2021 to 5 March 2021: | |||
| Number of A shares | Average purchase price A shares, DKK | Transaction value, A shares, DKK | |
| Accumulated, last announcement (market and A.P. Møller Holding A/S) | 29,974 | 373,604,544 | |
| 1 March 2021 | 250 | 12,671.4000 | 3,167,850 |
| 2 March 2021 | 230 | 12,720.8261 | 2,925,790 |
| 3 March 2021 | 240 | 12,696.6250 | 3,047,190 |
| 4 March 2021 | 250 | 12,514.2400 | 3,128,560 |
| 5 March 2021 | 220 | 12,554.1364 | 2,761,910 |
| Total 1-5 March 2021 | 1,190 | 15,031,300 | |
| Bought from A.P. Møller Holding A/S* 5 March 2021 | 1,261 | 12,631.3445 | 15,928,125 |
| Accumulated under the program (market and A. P. Møller Holding A/S) | 32,425 | 404,563,969 | |
| Number of B shares | Average purchase price B shares, DKK | Transaction value, B shares, DKK | |
| Accumulated, last announcement (market and A.P. Møller Holding A/S) | 119,901 | 1,611,564,142 | |
| 1 March 2021 | 1,200 | 13,683.1125 | 16,419,735 |
| 2 March 2021 | 1,200 | 13,767.0958 | 16,520,515 |
| 3 March 2021 | 1,200 | 13,735.0833 | 16,482,100 |
| 4 March 2021 | 1,200 | 13,487.9458 | 16,185,535 |
| 5 March 2021 | 1,150 | 13,491.9652 | 15,515,760 |
| Total 1-5 March 2021 | 5,950 | 81,123,645 | |
| Bought from A.P. Møller Holding A/S* 5 March 2021 | 3,809 | 13,634.2260 | 51,932,767 |
| Accumulated under the program (market and A. P. Møller Holding A/S) | 129,660 | 1,744,620,554 | |
| *) According to a separate agreement, A.P. Møller Holding A/S participates on a pro rata basis to the shares purchased in the share buy-back program. | |||
| With the transactions stated above, the Company owns a total of 141,295 A shares and 593,709 B shares as treasury shares, corresponding to 3.67% of the share capital. | |||
| | |||
| Details of each transaction are included as appendix. | |||
| Copenhagen, 8 March 2021 | |||
| Contact persons: | |||
| Head of Investor Relations, Stig Frederiksen, tel. +45 3363 3106 | |||
| Head of Media Relations, Signe Wagner, tel. +45 3363 1901 | |||
Attachments
- Announcement - Transactions in connection with share buy-back program (week 9 2021)
- Daily trades week 9
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Ilkka Oyj31.3.2026 18:00:00 CEST | Press release
Ilkka Oyj: Acquisition of own shares on 31 March 2026
Iveco Group N.V.31.3.2026 18:00:00 CEST | Press release
Iveco Group publishes the Informative Document concerning the sale of its Defence business
BioPorto A/S31.3.2026 17:43:41 CEST | Press release
BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis
BioPorto A/S31.3.2026 17:43:41 CEST | Pressemeddelelse
BioPorto indsender anmodning om FDA pre‑submission for amerikansk voksenprogram for urin‑NGAL efter positiv EPACRA‑analyse af AKI‑cut‑off
Kalmar Corporation31.3.2026 17:30:00 CEST | Press release
Kalmar’s Board of Directors’ constitutive meeting 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
